The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline
Open Access
- 9 August 2023
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (1) , 221-233
Abstract
INTRODUCTION: Tau and neurodegeneration strongly correlate with cognitive impairment, as compared to amyloid. However, their contribution in explaining cognition and predicting cognitive decline in memory clinics remains unclarified.METHODS: We included 94 participants with Mini‐Mental State Examination (MMSE), tau positron emission tomography (PET), amyloid PET, fluorodeoxyglucose (FDG) PET, and MRI scans from Geneva Memory Center. Linear regression and mediation analyses tested the independent and combined association between biomarkers, cognitive performance, and decline. Linear mixed‐effects and Cox proportional hazards models assessed biomarkers’ prognostic values.RESULTS: Metabolism had the strongest association with cognition (r = 0.712; p < 0.001), followed by tau (r = ‐0.682; p < 0.001). Neocortical tau showed the strongest association with cognitive decline (r = ‐0.677; p < 0.001). Metabolism mediated the association between tau and cognition and marginally mediated the one with decline. Tau positivity represented the strongest risk factor for decline (hazard ratio = 32).DISCUSSION: Tau and neurodegeneration synergistically contribute to global cognitive impairment while tau drives decline. The tau PET superior prognostic value supports its implementation in memory clinics.Highlights: Hypometabolism has the strongest association with concurrent cognitive impairment. Neocortical tau pathology is the main determinant of cognitive decline over time. FDG‐PET has a superior value compared to MRI as a measure of neurodegeneration. The prognostic value of tau‐PET exceeded all other neuroimaging modalities.Keywords
This publication has 64 references indexed in Scilit:
- BrainNet Viewer: A Network Visualization Tool for Human Brain ConnectomicsPLOS ONE, 2013
- Aβ-independent processes—rethinking preclinical ADNature Reviews Neurology, 2013
- FreeSurferNeuroImage, 2012
- Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvementBrain, 2012
- Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCINeurobiology of Aging, 2011
- Typical cerebral metabolic patterns in neurodegenerative brain diseasesMovement Disorders, 2010
- Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burdenBrain, 2010
- Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's diseaseBrain, 2007
- A fast diffeomorphic image registration algorithmNeuroImage, 2007
- Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentAnnals of Neurology, 1991